to-BBB is a clinical stage biotechnology company developing novel treatments for devastating brain disorders, such as brain cancer and neuroinflammatory diseases. The Company combines existing drugs with to-BBB’s proprietary G-Technology® for enhanced drug delivery across the blood-brain barrier.

Read more

Meet us at

European Symposium on Controlled Drug Delivery

» 16 April 2014

World Orphan Drug Congress - Washington

» 23 April 2014

Translational CNS Summit - Boston

» 29 April 2014